MUST-MITH: Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients. A Singel Arm Open Label Trial

Sponsor
Danish Headache Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06112587
Collaborator
(none)
30
1
1
7.3
4.1

Study Details

Study Description

Brief Summary

A Single-Arm Open-Label Trial was performed at the Danish Headache Center (DHC), Department of Neurology, Rigshospitalet - Glostrup as part of the clinic.

Purpose:

To examine the effects of supervised group strength training and posture correction on headache frequency and muscle function around the neck and shoulders in patients with migraine and tension-type headaches.

Hypothesis:

Strength training of the neck and shoulders results in improved muscle function, which leads to a reduction in headache.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: strength training
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
A Single-Arm Open-Label TrialA Single-Arm Open-Label Trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients.
Actual Study Start Date :
Oct 6, 2023
Anticipated Primary Completion Date :
May 15, 2024
Anticipated Study Completion Date :
May 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Migraine and tension-type headache patients

Patients diagnosed by a neurologist following the 3rd edition of the International Classification of Headaches Disorders (ICHD-III)

Behavioral: strength training
A targeted 8-week strength-training course was offered as an intervention in combination with ergonomics and posture corrections and recommendations

Outcome Measures

Primary Outcome Measures

  1. headache frequency [two weeks prior to intervention, last two weeks of intervention]

    number of days with headache

Secondary Outcome Measures

  1. neck pain maximal intensity [two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention]

    maximal neck pain intensity percieved by patient in a 0-10 NRPS

  2. neck pain average intensity [two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention]

    average neck pain intensity percieved by patient in a 0-10 NRPS

  3. neck pain frequency [two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention]

    number of days with neck pain

  4. headache duration [two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention]

    hours with headache

  5. medication intake [two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention]

    number of days with medication for pain taked

  6. Functional level [Before intervention, after intervention and at 1 month follow up]

    Self-reported limitated activities due to headache in a 0-10 scale thourgh the Patient-Specific Functional Scale

  7. Headache average Intensity [two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention]

    average headache intensity percieved by patient in a 0-10 NRPS

  8. Headache maximal Intensity [two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention]

    maximal headache intensity percieved by patient in a 0-10 NRPS

  9. headache frequency [weeks 4 and 5 after intervention]

    number of days with headache

Other Outcome Measures

  1. Maximal Voluntary Contraction of the Neck extension [Before intervention, after intervention and at 1 month follow up]

    Maximal force of the neck extension (Newtons)

  2. Maximal Voluntary Contraction of the Neck flexion [Before intervention, after intervention and at 1 month follow up]

    Maximal force of the neck flexion (Newtons)

  3. Maximal Voluntary Contraction of the Shoulder elevation [Before intervention, after intervention and at 1 month follow up]

    Maximal force of the shoulder elevation (Newtons)

  4. Moment arm for neck flexion and extension [Before intervention]

    Distance between C7 and Protuberancia occipitalis (m)

  5. Moment arm for shoulder elevation [Before intervention]

    Distance between C7 and acromion of the right shoulder (m)

  6. Moment arm for neck flexion [Before intervention, after intervention and at 1 month follow up]

    Peak of the Maximal Voluntary Contraction x Moment arm of the neck flexion (N*m)

  7. Moment arm of the neck extension [Before intervention, after intervention and at 1 month follow up]

    Peak of the Maximal Voluntary Contraction x Moment arm of the neck extension (N*m)

  8. Moment arm fof the shoulder elevation [Before intervention, after intervention and at 1 month follow up]

    Peak of the Maximal Voluntary Contraction x Moment arm of the shoulder elevation (N*m)

  9. Extension-Flexion ratio [Before intervention, after intervention and at 1 month follow up]

    Ratio between moment arm of the neck extension and moment arm of the neck flexion.

  10. Rate of force development of the shoulder elevation [Before intervention, after intervention and at 1 month follow up]

    (75% of the peak value of the shoulder elevation (N) - 25% of the peak value of the shoulder elevation)/(time at de 75% of the peak of shoulder elevation (s) - time at 25% of the peak of shoulder elevation) in Newtons per second (N/s)

  11. Early rate of force development of the shoulder elevation [Before intervention, after intervention and at 1 month follow up]

    (Value of the peak of the shoulder elevation at 250ms after the 2,5% of the peak (N) - 2,5% of the peak value of the shoulder elevation)/0,250 (s) in Newtons per second (N/s)

  12. Muscle tenderness [Before intervention, after intervention and at 1 month follow up]

    Total Tenderness Score (0-48)

  13. Muscle tenderness of the face [Before intervention, after intervention and at 1 month follow up]

    Total Tenderness Score of the first 4 spots: masseter, coronoid process, temporalis and frontalis (0-24)

  14. Muscle tenderness of the neck [Before intervention, after intervention and at 1 month follow up]

    Total Tenderness Score of the last 4 spots: mastoid process, sternocleidmastoid, occipitalis and superior trapezius (0-24)

  15. Craniocervical flexion score [Before intervention, after intervention and at 1 month follow up]

    Craniocervical flexion test score. Possible values: 20, 22, 24, 26, 28 or 30 mmHg

  16. Exercise sessions completed [During the intervention]

    Number of training sessions performed by the participants

  17. Percieved intensity [During the intervention]

    Level of intensity percieved by patients in each exercise session

  18. Intensity coherence [post-intervention]

    Ratio between average of rate of percieved exertion by the patients and 10 (coefficient from 0 to 1).

  19. Adherence of the programm [post-intervention]

    Ratio between the number of exercise sessions completed by patients versus number of exercise sessions planned in the programm

  20. Adherence to exercise [Week 1 to 5 after intervention]

    Ratio between the number of exercise sessions completed after intervention until the follow-up.

  21. Compliance of the programm [post-intervention]

    Product between intensity coherence and adherence.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Migraine patients with stable CGRP or botox.

  • Tension type headache with no more than 5 migraine days/month.

  • At least four days/months of headache at the moment of recruitment.

Exclusion Criteria:
  • Pregnancy

  • Post-traumatic headache, or headache that is likely to be associated with trauma.

  • Significant psychiatric comorbidities, such as severe depression

  • Medication Overuse Headaches.

  • Severe arthrosis in the neck, shoulder, or disc herniation in the neck.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Danish Headache Center Rigshospitalet - Glostrup Glostrup Denmark 2600

Sponsors and Collaborators

  • Danish Headache Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Bjarne Kjeldgaard Madsen, Principal Investigator, Danish Headache Center
ClinicalTrials.gov Identifier:
NCT06112587
Other Study ID Numbers:
  • DHC F-23036562
  • Danish Headache center
First Posted:
Nov 1, 2023
Last Update Posted:
Nov 1, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bjarne Kjeldgaard Madsen, Principal Investigator, Danish Headache Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 1, 2023